about
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repairEarly beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical painParacrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signalingConditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis.Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism.Endothelium-targeted gene and cell-based therapies for cardiovascular disease.Genetic therapies for cardiovascular diseases.Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.Mesenchymal stem cell therapy for heart disease.Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation.Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a "box of rain".[Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience].microRNA and Cardiac Regeneration.Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.Optimized lentiviral transduction of human amniotic mesenchymal stromal cells.Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair.Testing the Paracrine Properties of Human Mesenchymal Stem Cells Using Conditioned Medium.Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion-Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion.Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.Protocols for in vitro Differentiation of Human Mesenchymal Stem Cells into Osteogenic, Chondrogenic and Adipogenic Lineages.Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model.Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter FutureThe Unstoppable Attraction for Induced Pluripotent Stem CellsDifferent pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractionsLong QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem CellsEffectiveness of adjunctive stent implantation following directional coronary atherectomy for treatment of left anterior descending ostial stenosisCytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteriesEnhancing stem cell therapy through genetic modificationEvidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement
P50
Q28587325-10AAB285-9733-4E90-82AA-8AC18A75F2D5Q33862492-A246545B-4F09-4846-B923-EFF038EDD6F6Q35155303-3AC0086B-0BF1-4097-B9FA-2E355E1456F5Q35399206-E16679B8-5779-4E47-AF3E-ECFC31360E8AQ35552105-EE4F6147-DD33-4A38-B2B1-133C7BDE8D36Q35782003-C916F0D4-CE0A-4C4E-81FF-19244236A03AQ35861913-1D21A61E-0ECA-47F9-924A-8ACDE2E8CBA2Q36121285-8D0BD178-C28C-43FB-BEEE-26DB2FCA02EBQ36163172-CA0776E0-C4A4-40DF-AEA7-35361AF9F62BQ38004307-1B4F3861-B1DE-4BD3-BE06-918E17EEF6CFQ38730608-7A53A015-4350-4C3D-8AE7-7F27C8F90250Q38926005-365385A0-A066-48E9-95A9-C2131DFEE439Q39225825-71D9853D-C587-4D83-9629-3F836076F7CAQ40895838-2F7F3697-6D8C-41AE-B4BE-52F72686744AQ41370575-0B82C480-C556-4FA3-A9F1-F8F966916FC3Q44592644-2F294FF9-86E4-445F-9CC4-4F43AFC03693Q45874724-7214E643-E4F6-4E48-8C19-4ACDB5F3264DQ45881937-EA16E635-AE74-476C-9C23-4125E826A435Q46194651-BB7E6FEE-7D7E-4239-B6C7-8C471B90D822Q46362410-B66EAE04-2B05-4152-A3E9-7470FFDCF214Q46718093-44AAA5E0-7D41-46D7-87CA-A5007F874BD6Q46907260-AC4C12E0-B949-49D7-8C18-A179CD57310EQ47365824-AA6F1BC8-A743-4DC4-AC05-C54C9CA53AA3Q47552343-AFB642EB-04EC-4FCD-A790-3C0B7275820CQ47820046-7EB9A8CE-8453-4D15-8F02-9BE5FA8DFD22Q48708794-6507B6C7-DD60-4D7B-87C8-589152160F16Q50094161-C8A9B1BE-BC17-41C6-A0A2-27B5B017BD28Q50491161-3D77B4EC-2BED-427D-BC38-8EBB822E74F4Q50708387-58A9726C-724B-4E8E-84FB-0676A195E99AQ52717351-C0C347BE-262C-4D48-B19A-C70330D6D512Q52717923-22A152F8-6CBB-4EA0-9AE7-4723442E7CC9Q53792995-D9C8118A-7E82-482A-BEF9-BE36D45EA04AQ57159453-41D0E94F-8179-4A68-906D-B1B7AFA56B3CQ58010479-1DE9B1B6-E8BD-4976-9FC7-751231F3C189Q60300689-05C2F083-5AA7-4E03-81B7-767A4A3F5080Q64074244-569D0B26-53E6-4755-B626-AFAD30B9B064Q78493626-9BB2E443-4B3F-4AE5-BEDD-7E39A461F029Q80794984-91272958-4DC8-4024-A434-03F0053AD170Q81297176-1EF1A7DB-F076-4540-9841-58918AF25119Q83043116-6100FC6E-BCEB-4EF4-AAA9-40BEDB822D1D
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Massimiliano Gnecchi
@ast
Massimiliano Gnecchi
@en
Massimiliano Gnecchi
@es
Massimiliano Gnecchi
@nl
Massimiliano Gnecchi
@sl
type
label
Massimiliano Gnecchi
@ast
Massimiliano Gnecchi
@en
Massimiliano Gnecchi
@es
Massimiliano Gnecchi
@nl
Massimiliano Gnecchi
@sl
prefLabel
Massimiliano Gnecchi
@ast
Massimiliano Gnecchi
@en
Massimiliano Gnecchi
@es
Massimiliano Gnecchi
@nl
Massimiliano Gnecchi
@sl
P244
P1053
J-8609-2018
P106
P1153
6603047546
P21
P214
191146936720013781598
P244
nb2016012908
P31
P3829
P496
0000-0001-7435-4328
P7859
lccn-nb2016012908